Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination
Background: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has caused over 6 million deaths world-wide. In the pre-vaccination era, we noted a 5·3% SARS-CoV-2 IgG antibody positivity rate in 81,624 subjects. Methods: Utilizing assays for serum SARS-CoV-2 spike (S) protein...
Main Authors: | Latha Dulipsingh, Maxine Lang, Margaret R. Diffenderfer, Lisa Cook, Jennifer Puff, Lynn Diaz, Lihong He, Ernst J. Schaefer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Journal of Clinical Virology Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667038022000692 |
Similar Items
-
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies
by: Leonardo Vargas, et al.
Published: (2022-06-01) -
Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines
by: Avelino Albas, et al.
Published: (1998-08-01) -
Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
by: Jianhua Li, et al.
Published: (2022-12-01) -
Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
by: Alireza Abdollahi, et al.
Published: (2022-10-01) -
Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine
by: Hyemin Chung, et al.
Published: (2022-12-01)